NCT03869190 Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC) Status TERMINATED Phase PHASE1/PHASE2
NCT03768063 A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03748641 A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03586661 Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Status COMPLETED Phase PHASE1
NCT03016338 Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2